Erbium:YAG fractional laser ablation for the percutaneous delivery of intact functional therapeutic antibodies

Journal of Controlled Release

Volumn 156, Issue 1, 2011, Pages 53-59

  Yu, Jing ^a,b,c   Kalaria, Dhaval R ^a,b   Kalia, Yogeshvar N ^a,b  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Antithymocyte globulin; Basiliximab; Composite tissue allotransplantation; Laser assisted microporation; Topical delivery; Transdermal delivery

Indexed keywords

ABLATION; BIOACTIVITY; ERBIUM; LASER ABLATION; YTTRIUM ALUMINUM GARNET;

ANTITHYMOCYTE GLOBULIN; BASILIXIMAB; COMPOSITE TISSUES; LASER-ASSISTED; TOPICAL DELIVERY; TRANSDERMAL DELIVERY;

ANTIBODIES;

BASILIXIMAB; THYMOCYTE ANTIBODY;

ARTICLE; CYTOTOXIC T LYMPHOCYTE; DRUG DELIVERY SYSTEM; ENZYME LINKED IMMUNOSORBENT ASSAY; ERBIUM YAG LASER; HUMAN; IMMUNE DEFICIENCY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LASER SURGERY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN; WESTERN BLOTTING;

EID: 80855138131     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2011.07.024     Document Type: Article

References (42)

1. B. Leader, Q.J. Baca, and D.E. Golan Protein therapeutics: a summary and pharmacological classification Nat. Rev. Drug Discovery 7 1 2008 21 39
2. W.R. Strohl, and D.M. Knight Discovery and development of biopharmaceuticals: current issues Curr. Opin. Biotechnol. 20 6 2009 668 672
3. M.E. Chamuleau, A.A. van de Loosdrecht, and P.C. Huijgens Monoclonal Antibody therapy in haematological malignancies Curr Clin. Pharmacol. 5 3 2010 148 159
4. F. Perosa, M. Prete, V. Racanelli, and F. Dammacco CD20-depleting therapy in autoimmune diseases: from basic research to the clinic J. Intern. Med. 267 3 2010 260 277
5. D. Schrama, R.A. Reisfeld, and J.C. Becker Antibody targeted drugs as cancer therapeutics Nat. Rev. Drug Discovery 5 2 2006 147 159
6. S.B. Bressler Introduction: understanding the role of angiogenesis and antiangiogenic agents in age-related macular degeneration Ophthalmology 116 10 Suppl 2009 S1 S7
7. M.E. Sockolov, A. Alikhan, and O. Zargari Non-psoriatic dermatologic uses of monoclonal antibody therapy J. Dermatol. Treat. 20 6 2009 319 327
8. B. Gander, C.S. Brown, D. Vasilic, A. Furr, J.C. Banis Jr., M. Cunningham, O. Wiggins, C. Maldonado, I. Whitaker, G. Perez-Abadia, J.M. Frank, and J.H. Barker Composite tissue allotransplantation of the hand and face: a new frontier in transplant and reconstructive surgery Transpl. Int. 19 11 2006 868 880 (Pubitemid 44511110)
9. V.S. Gorantla, J.H. Barker, J.W. Jones Jr., K. Prabhune, C. Maldonado, and D.K. Granger Immunosuppressive agents in transplantation: mechanisms of action and current anti-rejection strategies Microsurgery 20 8 2000 420 429 (Pubitemid 32044150)
10. S.A. Gruber, M.V. Shirbacheh, J.W. Jones, J.H. Barker, and W.C. Breidenbach Local drug delivery to composite tissue allografts Microsurgery 20 8 2000 407 411 (Pubitemid 32044148)
11. A. Naik, Y.N. Kalia, and R.H. Guy Transdermal drug delivery: overcoming the skin's barrier function Pharm. Sci. Technol. Today 3 9 2000 318 326
12. P.M. Elias, and E.H. Choi Interactions among stratum corneum defensive functions Exp. Dermatol. 14 10 2005 719 726 (Pubitemid 41419458)
13. M.R. Prausnitz, S. Mitragotri, and R. Langer Current status and future potential of transdermal drug delivery Nat. Rev. Drug Discovery 3 2 2004 115 124 (Pubitemid 38239773)
14. P. Karande, A. Jain, and S. Mitragotri Discovery of transdermal penetration enhancers by high-throughput screening Nat. Biotechnol. 22 2 2004 192 197 (Pubitemid 38160534)
15. Y. Chen, Y. Shen, X. Guo, C. Zhang, W. Yang, M. Ma, S. Liu, M. Zhang, and L.P. Wen Transdermal protein delivery by a coadministered peptide identified via phage display Nat. Biotechnol. 24 4 2006 455 460
16. M. Ogura, S. Paliwal, and S. Mitragotri Low-frequency sonophoresis: current status and future prospects Adv. Drug Deliv. Rev. 60 10 2008 1218 1223
17. S. Dubey, and Y.N. Kalia Non-invasive iontophoretic delivery of enzymatically active ribonuclease A (13.6 kDa) across intact porcine and human skins J. Control. Release 145 2010 203 209
18. G. Li, A. Badkar, S. Nema, C.S. Kolli, and A.K. Banga In vitro transdermal delivery of therapeutic antibodies using maltose microneedles Int. J. Pharm. 368 1-2 2009 109 115
19. Y.G. Bachhav, Y.N. Kalia, T. Bragagna, and C. Böhler Intraepidermal drug delivery: P.L.E.A.S.E.® - a new laser microporation technology Drug Deliv. Technol. 8 2008 26 31
20. Y.G. Bachhav, S. Summer, A. Heinrich, T. Bragagna, C. Böhler, and Y.N. Kalia Effect of controlled laser microporation on drug transport kinetics into and across the skin J. Control. Release 146 1 2010 31 36
21. Y.G. Bachhav, A. Heinrich, and Y.N. Kalia Using laser microporation to improve transdermal delivery of diclofenac: increasing bioavailability and the range of therapeutic applications Eur. J. Pharm. Biopharm. 78 3 2011 408 414
22. N.H. Zech, M. Murtinger, and P. Uher Pregnancy after ovarian superovulation by transdermal delivery of follicle-stimulating hormone Fertil. Steril. 95 8 2011 2784 2785
23. P.L. Yun, R. Tachihara, and R.R. Anderson Efficacy of erbium:yttrium-aluminum-garnet laser-assisted delivery of topical anesthetic J. Am. Acad. Dermatol. 47 4 2002 542 547
24. K.H. Wang, J.Y. Fang, C.H. Hu, and W.R. Lee Erbium:YAG laser pretreatment accelerates the response of Bowen's disease treated by topical 5-fluorouracil Dermatol. Surg. 30 3 2004 441 445
25. J.Y. Fang, W.R. Lee, S.C. Shen, H.Y. Wang, C.L. Fang, and C.H. Hu Transdermal delivery of macromolecules by erbium:YAG laser J. Control. Release 100 1 2004 75 85
26. S.C. Shen, W.R. Lee, Y.P. Fang, C.H. Hu, and J.Y. Fang In vitro percutaneous absorption and in vivo protoporphyrin IX accumulation in skin and tumors after topical 5-aminolevulinic acid application with enhancement using an erbium:YAG laser J. Pharm. Sci. 95 4 2006 929 938
27. W.R. Lee, S.C. Shen, C.R. Liu, C.L. Fang, C.H. Hu, and J.Y. Fang Erbium:YAG laser-mediated oligonucleotide and DNA delivery via the skin: an animal study J. Control. Release 115 3 2006 344 353
28. W.R. Lee, T.L. Pan, P.W. Wang, R.Z. Zhuo, C.M. Huang, and J.Y. Fang Erbium:YAG laser enhances transdermal peptide delivery and skin vaccination J. Control. Release 128 3 2008 200 208
29. W.R. Lee, S.C. Shen, C.L. Fang, R.Z. Zhuo, and J.Y. Fang Topical delivery of methotrexate via skin pretreated with physical enhancement techniques: low-fluence erbium:YAG laser and electroporation Lasers Surg. Med. 40 7 2008 468 476
30. W.R. Lee, S.C. Shen, R.Z. Zhuo, K.C. Wang, and J.Y. Fang Enhancement of topical small interfering RNA delivery and expression by low-fluence erbium:YAG laser pretreatment of skin Hum. Gene Ther. 20 6 2009 580 588
31. W.R. Lee, S.C. Shen, M.H. Pai, H.H. Yang, C.Y. Yuan, and J.Y. Fang Fractional laser as a tool to enhance the skin permeation of 5-aminolevulinic acid with minimal skin disruption: a comparison with conventional erbium:YAG laser J. Control. Release 145 2 2010 124 133
32. W.R. Lee, S.C. Shen, S.A. Al-Suwayeh, H.H. Yang, C.Y. Yuan, and J.Y. Fang Laser-assisted topical drug delivery by using a low-fluence fractional laser: Imiquimod and macromolecules J. Control. Release 2011 http://dx.doi.org/10.1016/ j.jconrel.2011.03.015
33. B. Forster, A. Klein, R.M. Szeimies, and T. Maisch Penetration enhancement of two topical 5-aminolaevulinic acid formulations for photodynamic therapy by erbium:YAG laser ablation of the stratum corneum: continuous versus fractional ablation Exp. Dermatol. 19 9 2010 806 812
34. U.K. Laemmli Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 5259 1970 680 685
35. F. Ayuk, N. Maywald, S. Hannemann, U. Larsen, A. Zander, and N. Kroger Comparison of the cytotoxicity of 4 preparations of anti-T-cell globulins in various hematological malignancies Anticancer. Res. 29 4 2009 1355 1360
36. I.P. Dick, and R.C. Scott Pig ear skin as an in-vitro model for human skin permeability J. Pharm. Pharmacol. 44 8 1992 640 645
37. N. Sekkat, Y.N. Kalia, and R.H. Guy Biophysical study of porcine ear skin in vitro and its comparison to human skin in vivo J. Pharm. Sci. 91 11 2002 2376 2381 (Pubitemid 35231200)
38. C.J. Brown, and T.M. Donnelly Rodent husbandry and care Vet. Clin. North Am. Exot. Anim. Pract. 7 2 2004 201 225 v (Pubitemid 38618739)
39. O. Penack, L. Fischer, C. Gentilini, A. Nogai, A. Muessig, K. Rieger, S. Ganepola, E. Thiel, and L. Uharek The type of ATG matters - natural killer cells are influenced differentially by Thymoglobulin, Lymphoglobulin and ATG-Fresenius Transpl. Immunol. 18 2 2007 85 87 (Pubitemid 350086951)
40. D. Stauch, A. Dernier, E. Sarmiento Marchese, K. Kunert, H.D. Volk, J. Pratschke, and K. Kotsch Targeting of natural killer cells by rabbit antithymocyte globulin and campath-1H: similar effects independent of specificity PLoS One 4 3 2009 e4709
41. M.C. Michallet, X. Preville, M. Flacher, S. Fournel, L. Genestier, and J.P. Revillard Functional antibodies to leukocyte adhesion molecules in antithymocyte globulins Transplantation 75 5 2003 657 662 (Pubitemid 36337364)
42. T. Hautz, B. Zelger, J. Grahammer, C. Krapf, A. Amberger, G. Brandacher, L. Landin, H. Muller, M.P. Schon, P. Cavadas, A.W. Lee, J. Pratschke, R. Margreiter, and S. Schneeberger Molecular markers and targeted therapy of skin rejection in composite tissue allotransplantation Am. J. Transplant. 10 5 2010 1200 1209